Central Nervous System News and Research

RSS

How caffeine impacts cerebral blood flow

Caffeine consumption affects cerebral blood flow in young adults, with the study showing a dose-dependent reduction in arterial velocity post-intake. This impact on the cardiovascular system suggests caffeine's vasodilatory effects on cerebral arteries.

5 Nov 2023

Brain peptides activate GH–IGF-1 axis to prevent the progression of MASLD, study reveals

Various factors including obesity, diabetes, etc. are related to the etiology of steatotic liver disease (SLD) including metabolic dysfunction-associated steatotic liver disease (MASLD) etiology and resulted in the complications in various organs.

2 Nov 2023

Researchers identify key protein biomarkers in MS patients, paving way for personalized treatment strategies

Researchers aimed to identify dependable protein biomarkers for multiple sclerosis (MS).

1 Nov 2023

Marijuana's psychoactive compound may alter brain wiring in adolescents

In a mouse study designed to explore the impact of marijuana's major psychoactive compound, THC, on teenage brains, Johns Hopkins Medicine researchers say they found changes to the structure of microglia, which are specialized brain immune cells, that may worsen a genetic predisposition to schizophrenia.

25 Oct 2023

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

25 Oct 2023

AI-based MRI tools show promise in multiple sclerosis diagnosis

A groundbreaking study in NPJ Digital Medicine demonstrates the superior accuracy of AI-based imaging in diagnosing and monitoring multiple sclerosis.

23 Oct 2023

Is COVID-19 a risk factor for Alzheimer's disease?

The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.

23 Oct 2023

Sugar-sweetened beverages pose a potential risk of ADHD

The consumption of sugar-sweetened beverages was associated with ADHD.

19 Oct 2023

How the gut microbiome contributes to schizophrenia

Researchers explore potential relationships between schizophrenia, the gut microbiome, the gut-brain axis, and short-chain fatty acids.

19 Oct 2023

How do different organ microbiomes influence neuropsychiatric disorders?

Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.

19 Oct 2023

Turning brain immune cells into neurons restores brain function after stroke-like injury in mice

Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice.

18 Oct 2023

FAST joins with University of Pennsylvania to develop investigational AAV gene therapy for Angelman syndrome

The Foundation for Angelman Syndrome Therapeutics (FAST) announced today that the non-profit organization has entered into an exclusive global collaborative research and development agreement with the University of Pennsylvania to develop an investigational adeno-associated virus (AAV) gene therapy for Angelman syndrome (AS).

17 Oct 2023

SwRI develops unique technology for safe and efficient synthesis of OPNA oxime antidotes

Southwest Research Institute has developed a unique technology (US20230242487A1) that enables the safe and efficient synthesis of organophosphorus nerve agent (OPNA) oxime antidotes.

17 Oct 2023

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine ("Insilico") has been invited to present scientific data on its novel anti-cancer assets at three major upcoming cancer conferences -- the European Society for Medical Oncology (ESMO) conference in Madrid Oct. 20-24, 2023; the Society of Immunotherapy of Cancer (SITC) conference Nov. 1-5, 2023 in San Diego; and the San Antonio Breast Cancer Symposium (SABCS) Dec. 5-9, 2023.

16 Oct 2023

Researchers identify new biomarker to predict neuronal regeneration after injury

Neurons, the main cells that make up our brain and spinal cord, are among the slowest cells to regenerate after an injury, and many neurons fail to regenerate entirely.

16 Oct 2023

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of CNS malignancies.

16 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

Ketogenic diets found to slash migraine frequency and fatigue in new study

Italian researchers find that ketogenic diets not only reduce the frequency and intensity of migraines but also significantly alleviate fatigue in sufferers. The study opens new doors for alternative, diet-based therapies for chronic and high-frequency episodic migraineurs.

12 Oct 2023

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Researchers in neuropsychopharmacology challenge conventional wisdom about antidepressants' actions, revealing significant intracellular activity that influences their effectiveness. Utilizing advanced technologies, the study prompts a reevaluation of drug targeting and mechanisms, opening new avenues for treating depression.

12 Oct 2023

Could young blood be the key to reversing age-related cognitive decline?

Researchers at the University of Auckland identify platelet factor 4 (PF4) in young blood as a key player in reversing age-related cognitive decline in mice. The study offers a promising avenue for treating dementia-related conditions and enhancing brain function in aging populations.

11 Oct 2023

Central Nervous System News and Research

How caffeine impacts cerebral blood flow

Brain peptides activate GH–IGF-1 axis to prevent the progression of MASLD, study reveals

Researchers identify key protein biomarkers in MS patients, paving way for personalized treatment strategies

Marijuana's psychoactive compound may alter brain wiring in adolescents

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

AI-based MRI tools show promise in multiple sclerosis diagnosis

Is COVID-19 a risk factor for Alzheimer's disease?

Sugar-sweetened beverages pose a potential risk of ADHD

How the gut microbiome contributes to schizophrenia

How do different organ microbiomes influence neuropsychiatric disorders?

Turning brain immune cells into neurons restores brain function after stroke-like injury in mice

FAST joins with University of Pennsylvania to develop investigational AAV gene therapy for Angelman syndrome

SwRI develops unique technology for safe and efficient synthesis of OPNA oxime antidotes

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Researchers identify new biomarker to predict neuronal regeneration after injury

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

Are migraines linked to gut health and chronic non-communicable diseases?

Ketogenic diets found to slash migraine frequency and fatigue in new study

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Could young blood be the key to reversing age-related cognitive decline?

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News